Tumores Ginecológicos

Estudo de coorte | Associação de linfedema de membro inferior com função física e atividades de vida diária entre idosos sobreviventes de câncer colorretal, endometrial e ovariano.

29 Mar, 2022 | 13:53h

Association of Lower Extremity Lymphedema With Physical Functioning and Activities of Daily Living Among Older Survivors of Colorectal, Endometrial, and Ovarian Cancer – JAMA Network Open

Comentários:

Older female cancer survivors face challenges with physical activity due to chronic lower extremity lymphedema – News Medical

Lower-Extremity Lymphedema Common in Older, Female Cancer Survivors – HealthDay

 

Comentário no Twitter

Cohort study found nearly 1/3 of older female survivors of #ColorectalCancer, #EndometrialCancer, or #OvarianCancer have lower-extremity lymphedema (LEL), which is associated with worse physical function and needing assistance with ADLs. https://t.co/806Tt88TuV

— JAMA Network Open (@JAMANetworkOpen) March 9, 2022

 

---

Diretrizes clínicas da SEOM-GEICO sobre câncer endometrial.

25 Mar, 2022 | 15:18h

SEOM-GEICO clinical guidelines on endometrial cancer (2021) – Clinical and Translational Oncology

---

[Comunicado de imprensa – ainda não publicado] Estudo randomizado | Abordagem minimamente invasiva para histerectomia no câncer de colo do útero está associada à pior sobrevida livre de doença do que a cirurgia aberta.

25 Mar, 2022 | 14:49h

Minimally Invasive Approach to Hysterectomy in Cervical Cancer Associated with Poorer Disease-Free Survival Than Open Surgery – Society of Gynecologic Oncology

---

M-A | Risco de carcinomatose peritoneal após redução do risco por salpingo-ooforectomia em portadoras da variante patogênica BRCA1/2.

23 Mar, 2022 | 11:24h

Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis – Journal of Clinical Oncology

---

Plano de cuidado multidisciplinar do câncer de ovário em pacientes idosos.

21 Mar, 2022 | 15:59h

Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO – Cancers

---

Tendências de tumores associados ao HPV, características demográficas e vacinação nos EUA, 2001-2017.

17 Mar, 2022 | 12:46h

Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017 – JAMA Network Open

Entrevista com o autor: Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations

Conteúdos relacionados:

[Not published yet] Single-dose HPV vaccine highly effective, researchers say – “Results of randomized controlled trial in Kenya bring new energy to eliminate cervical cancer worldwide”.

A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

---

Revisão sistemática | Programas perioperatórios de recuperação melhorada (enhanced recovery after surgery) para mulheres com câncer ginecológico.

16 Mar, 2022 | 17:50h

Perioperative enhanced recovery programmes for women with gynaecological cancers – Cochrane Library

Ver também: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines (algumas diretrizes têm acesso gratuito)

---

Estudo randomizado | Em mulheres submetidas a cirurgia citorredutora para câncer de ovário, a adição de quimioterapia intraperitoneal hipertérmica não melhorou a progressão livre de doença e a sobrevida geral.

16 Mar, 2022 | 17:35h

Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial – JAMA Surgery

Conteúdos relacionados:

M-A: Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer.

RCT: Cytoreductive surgery for relapsed ovarian cancer.

Guide to enhanced recovery for cancer patients undergoing surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without hyperthermic intraperitoneal chemotherapy.

---

Revisão sistemática | Inibidores da poli(ADP-ribose) polimerase (PARP) para tratamento do câncer de ovário.

14 Mar, 2022 | 13:47h

Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer – Cochrane Library

---

Atualização da diretriz ASCO de recomendações estratificadas por disponibilidade de recursos | Tratamento de cuidado de pacientes com câncer de colo do útero invasivo.

14 Mar, 2022 | 13:22h

Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update – JCO Global Oncology

Comunicado de imprensa: ASCO Guideline Recommends Addition of Monoclonal Antibody to Invasive Cervical Cancer Management – ASCO Daily News

---